Ken Fisher Explains What’s Next For Healthcare Stocks

The swift development of vaccines to combat COVID-19 is tremendous news that could help save many lives, but is it great news for healthcare stocks, too? In this video, Ken Fisher, investor and founder of Fisher Investments, considers how healthcare stocks might react to vaccine development and rollout.
The stock market is forward-looking and quickly incorporates any widely known information into stock prices, Ken explains. The more some piece of information is in the news, the more likely that information is already incorporated into the price of a stock. COVID-19 and the development of vaccines are some of the most widely followed and widely reported topics in the world. Consequently, Ken believes current stock prices already reflect potential upside tied to vaccine success.
Moreover, Ken explains that the effects of the vaccine development and distribution are likely to have only minimal impacts on healthcare stocks because these companies aren’t likely to make a great deal of money off the venture. This doesn’t lessen the overall societal good, but it does weaken the investment thesis for these types of stocks as it relates to vaccine development.
If you would like to learn more of Ken Fisher’s and Fisher Investments’ thoughts on the current environment and where markets could go from here, visit us at https://www.fisherinvestments.com/en-us.
Connect with us on:
Facebook - https://www.facebook.com/FisherInvestments
Twitter - https://twitter.com/fisherinvest
LinkedIn - https://www.linkedin.com/company/fisher-investments

Видео Ken Fisher Explains What’s Next For Healthcare Stocks канала Fisher Investments